Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic skin-derived ABCB5-positive MSCs allo-APZ2-OTS

A preparation of off-the-shelf (OTS) allogeneic human dermal ex-vivo expanded mesenchymal stromal cells (MSCs) expressing the ATP-binding cassette (ABC) efflux transporter, subfamily B, member 5 (ABCB5) that can potentially be used in the treatment of various skin-related and systemic inflammatory and degenerative conditions, such as recessive dystrophic epidermolysis bullosa (RDEB). Upon administration of the allo-APZ2-OTS, the MSCs are able to differentiate into several lineages, provide immunomodulatory activity, interact with various immune cells, such as macrophages, neutrophils and regulatory T cells (Tregs), and are able to secrete various anti-inflammatory mediators and pro-angiogenic molecules. Altogether, allo-APZ2-OTS may contribute to inflammation control and tissue repair.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic skin-derived ABCB5-positive mesenchymal stem cells allo-APZ2-OTS
Code name:allo-APZ2-OTS
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search